Transaction in Own Shares

Summary by AI BETAClose X

CT Healthcare Trust PLC announced the purchase of 213 ordinary shares at an average price of 121.19 pence per share on October 12, 2026, through J.P. Morgan Securities plc on the LSE. These shares will be held in treasury, bringing the total treasury shares to 272,823,672, with 42,328,637 ordinary shares remaining in issue.

Disclaimer*

CT Healthcare Trust PLC
13 October 2026
 









CT Healthcare Trust plc

 


Transaction in own shares

 










CT Healthcare Trust plc (the "Company") announces that it purchased the following number of its ordinary shares of 1 penny each through J.P. Morgan Securities plc.







Date of purchase:

12 October 2026



Number of ordinary shares purchased:

213



Trading venue

LSE



Average price paid per share:

121.19p







The Company intends to hold the purchased shares in treasury.







Following the above transaction, the Company holds 272,823,672 of its ordinary shares in treasury and has 42,328,637 ordinary shares in issue (excluding treasury shares).







The Company's LEI is: 213800HQ3J3H9YF2UI82








Enquiries:

 



 Columbia Threadneedle Investments

 



 Telephone: +44 (0) 207 464 5000








 J.P. Morgan Cazenove

 



 James Bouverat (Sales)




 Telephone: +44 (0) 207 134 2224



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings